×
Hero Background

Multiplex Assays Companies

ID: MRFR/HC/4677-HCR
90 Pages
Rahul Gotadki
October 2025

Multiplex Assays companies are pioneers in advanced diagnostic technologies. Specializing in research, development, and distribution, these organizations provide cutting-edge assays that allow simultaneous analysis of multiple biomarkers, revolutionizing the efficiency and accuracy of diagnostic processes.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Multiplex Assays Market

Multiplex Assays Market

 


Latest Multiplex Assays Companies Updates:


Luminex Corporation acquired by DiaSorin S.p.A. in a USD 1.8 billion deal: This consolidation strengthens DiaSorin's position in the multiplex assay market, particularly in molecular diagnostics.


Becton, Dickinson and Company (BD) launched its BD COR System: This fully automated system leverages robotics and software to set a new standard in workflow efficiency for infectious disease molecular testing.


InDevR, Inc. launched a VaxArray Pneumococcal Assay kits: This rapid and accurate multiplex assay assesses pneumococcal vaccines at various stages of manufacturing.


Vela Diagnostics launched PathoKey MP UTI ID and AMR PCR Test: This research-use tool offers simultaneous identification and antibiotic susceptibility testing for urinary tract infections.Sentinel Diagnostics launched SentiNat 200 and Stat-Nat SN200 Real-Time PCR assays: This fully automated system and assays enable quantitative detection of 10 viruses common in respiratory infections.


List of Multiplex Assays companies in the market:



  • Thermo Fisher Scientific Inc

  • Illumina Inc

  • Bio-Rad Laboratories Inc

  • Qiagen

  • Abcam plc

  • BD

  • Merck Sharp & Dohme Corp

  • Agilent Technologies

  • Meso Scale Diagnostics LLC

  • Randox Laboratories Ltd